Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:11-HDoHE)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004132 AN006849 Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. Blood Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004132 AN006849 Metabolite profiling of portal plasma, cardiac puncture plasma, and cecal contents of 129 T, 129 J, C57Bl6 mice. Cecal content Mouse Diabetes Broad Institute of MIT and Harvard LC-MS
ST004086 AN006773 Quantification of Levels of EETs and DHETs in murine plasma in Abdominal aortic constriction (AAC)-induced cardiac hypertrophy model using LC-MS Blood Mouse Second Xiangya Hospital of Central South University LC-MS
ST003931 AN006454 Acylated putrescine therapeutic discovery for Inflammatory Bowel Diseases: HILIC-neg, C8-pos and C18-neg profiling of mouse fecal samples Feces Mouse Inflammatory bowel disease Broad Institute of MIT and Harvard LC-MS
ST003788 AN006446 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Meningitis Broad Institute of MIT and Harvard LC-MS
ST003788 AN006446 Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis reveals multiple pathways associated with mortality Cerebrospinal fluid Human Tuberculosis Broad Institute of MIT and Harvard LC-MS
ST003534 AN005805 Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction Heart Mouse Cardiovascular disease Tianjin Medical University LC-MS
ST003534 AN005805 Metabolomic analysis of altered arachidonic acid metabolism in mouse heart tissue after myocardial infarction Heart Mouse Inflammation Tianjin Medical University LC-MS
ST003137 AN005150 Lipid class-specific kinetics of plasma fatty acids, oxylipins, endocannabinoids, lysophospholipids and bile acids upon a lipopolysaccharide challenge of healthy humans and their modulation by anti-oxidative supplements (Part 1/2 - negative mode) Blood Human University of Vienna LC-MS
ST003049 AN005000 Plasma instead of serum avoids critical confounding of clinical metabolomics studies by platelets Blood Human University of Vienna LC-MS
ST002823 AN004604 Smoking Induced Gut Microbial Dysbiosis Mediates Cancer Progression Through Adaptive Immune System Modulation Feces Mouse Cancer University of Alabama, Birmingham LC-MS
ST002471 AN004036 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling Feces Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002470 AN004032 Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human plasma profiling Blood Human Ulcerative colitis Broad Institute of MIT and Harvard LC-MS
ST002455 AN004005 Organism-Wide Analysis of Sepsis Reveals Mechanisms of Systemic Inflammation Blood Mouse Sepsis University of Chicago LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003843 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Blood Rat Cancer UConn Health LC-MS
ST002354 AN003845 Combination of TP-252 and Naproxen elicit tumor protective Eicosanoid changes. Colon Rat Cancer UConn Health LC-MS
ST002247 AN003673 Microbiota and Health Study (Dhaka, Bangladesh) Feces Human Broad Institute of MIT and Harvard LC-MS
ST002246 AN003669 Longitudinal fecal metabolomic profiles from mothers and their infants in the EDIA study Feces Human Broad Institute of MIT and Harvard LC-MS
ST001951 AN003176 Quantification of ω-3 fatty acids and their derivatives in lungs from hypoxia-induced pulmonary hypertension (PH) mice. Lung Mouse Pulmonary hypertension University of Tokyo LC-MS
ST001215 AN002026 Effect of Mirabegron Treatment on serum lipidome Blood Human Joslin Diabetes Center LC-MS
ST001214 AN002025 Lipidommics in the serum of human subjects Blood Human Joslin Diabetes Center LC-MS
ST001213 AN002024 Serum lipidomic profile of cold-exposed Ucp1cre/12-LOX KO mice Blood Mouse Joslin Diabetes Center LC-MS
ST001207 AN002009 Lipidomics in the serum of cold exposed mice treated with 12-LOX inhibitor LOXBlock-1 Blood Mouse Joslin Diabetes Center LC-MS
ST001206 AN002008 Effects of cold exposure on serum lipidomic in mice Blood Mouse Joslin Diabetes Center LC-MS
ST000916 AN001491 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma Blood Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000915 AN001485 Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver Liver Human Fatty liver disease LIPID MAPS GC-MS/LC-MS
ST000004 AN000004 Lipidomics studies on NIDDK / NIST human plasma samples Blood Human LIPID MAPS LC-MS
  logo